These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23974052)

  • 1. Leishmania donovani: influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis.
    Shivam P; Jamal F; Kumari S; Bimal S; Narayan S; Das VN; Pandey K; Gupta AK; Singh D; Verma N; Das P; Singh SK
    Hum Immunol; 2013 Dec; 74(12):1575-8. PubMed ID: 23974052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
    Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
    Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania donovani resistant to Ambisome or Miltefosine exacerbates CD58 expression on NK cells and promotes trans-membrane migration in association with CD2.
    Shivam P; Kumari S; Jamal F; Kumar V; Kumar M; Bimal S; Narayan S; Das VNR; Pandey K; Gupta AK; Das P; Singh SK
    Cytokine; 2017 Aug; 96():54-58. PubMed ID: 28324803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.
    Nylén S; Maurya R; Eidsmo L; Manandhar KD; Sundar S; Sacks D
    J Exp Med; 2007 Apr; 204(4):805-17. PubMed ID: 17389235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
    Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India.
    Singh SK; Bimal S; Narayan S; Jee C; Bimal D; Das P; Bimal R
    Exp Parasitol; 2011 Feb; 127(2):552-8. PubMed ID: 21070771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 enhances Th1-type responses in human Leishmania donovani infections.
    Ghalib HW; Whittle JA; Kubin M; Hashim FA; el-Hassan AM; Grabstein KH; Trinchieri G; Reed SG
    J Immunol; 1995 May; 154(9):4623-9. PubMed ID: 7722314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10 and the pathogenesis of human visceral leishmaniasis.
    Nylén S; Sacks D
    Trends Immunol; 2007 Sep; 28(9):378-84. PubMed ID: 17689290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
    Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
    Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasis.
    Kumari S; Jamal F; Shivam P; Thakur A; Kumar M; Bimal S; Das VN; Pandey K; Narayan S; Gupta AK; Das P; Singh SK
    Cytokine; 2015 May; 73(1):53-60. PubMed ID: 25697139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania donovani: effect of therapy on expression of CD2 antigen and secretion of macrophage migration inhibition factor by T-cells in patients with visceral leishmaniasis.
    Bimal S; Singh SK; Das VN; Sinha PK; Gupta AK; Bhattacharya SK; Das P
    Exp Parasitol; 2005 Oct; 111(2):130-2. PubMed ID: 16023642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupeol and amphotericin B mediate synergistic anti-leishmanial immunomodulatory effects in Leishmania donovani-infected BALB/c mice.
    Das A; Jawed JJ; Das MC; Parveen S; Ghosh C; Majumdar S; Saha B; Bhattacharjee S
    Cytokine; 2021 Jan; 137():155319. PubMed ID: 33002744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania donovani: role of CD2 on CD4+ T-cell function in Visceral Leishmaniasis.
    Bimal S; Singh SK; Sinha S; Pandey K; Sinha PK; Ranjan A; Bhattacharya SK; Das P
    Exp Parasitol; 2008 Feb; 118(2):238-46. PubMed ID: 17904553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression during Leishmania donovani infection: a potential target for the development of therapy.
    Flora R; Aghazadeh-Dibavar S; Bandyopadhyay M; Dasgupta S
    Ann Parasitol; 2014; 60(4):239-45. PubMed ID: 25706420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis.
    Amit A; Chaudhary R; Yadav A; Suman SS; Narayan S; Das VN; Pandey K; Singh SK; Singh BK; Ali V; Das P; Bimal S
    Cell Immunol; 2014; 289(1-2):76-85. PubMed ID: 24732062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
    Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
    FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis.
    Mallick S; Halder S; Dutta A; Dey S; Paul K; Maiti S; Bandyopadhyay C; Saha B; Pal C
    Int Immunopharmacol; 2013 Apr; 15(4):772-9. PubMed ID: 23499679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implications for disease pathogenesis.
    Elshafie AI; Ahlin E; Mathsson L; ElGhazali G; Rönnelid J
    J Immunol; 2007 Apr; 178(8):5383-9. PubMed ID: 17404324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.